Five Prime Therapeutics Inc (FPRX)

36.05
0.99 2.67
NASDAQ : Health Care
Prev Close 37.04
Open 36.83
Day Low/High 35.19 / 37.55
52 Wk Low/High 14.70 / 50.11
Volume 912.97K
Avg Volume 388.50K
Exchange NASDAQ
Shares Outstanding 28.96M
Market Cap 1.14B
EPS -2.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

European Commission Grants Orphan Drug Designation To Cabiralizumab (FPA008) For Pigmented Villonodular Synovitis (PVNS)

European Commission Grants Orphan Drug Designation To Cabiralizumab (FPA008) For Pigmented Villonodular Synovitis (PVNS)

Cabiralizumab (FPA008) is in a Phase 2 clinical trial for rare neoplastic joint disease for which there are no currently approved treatments

Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers

Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers

Shares tanked Wednesday on little more than a two-sentence comment from the president-elect.

Five Prime Therapeutics Reaches Analyst Target Price

Five Prime Therapeutics Reaches Analyst Target Price

In recent trading, shares of Five Prime Therapeutics, Inc have crossed above the average analyst 12-month target price of $56.00, changing hands for $57.76/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Today Five Prime Therapeutics (FPRX) Hits New Lifetime High

Today Five Prime Therapeutics (FPRX) Hits New Lifetime High

Trade-Ideas LLC identified Five Prime Therapeutics (FPRX) as a new lifetime high candidate

Short Interest Expands By 18% For FPRX

Short Interest Expands By 18% For FPRX

The most recent short interest data has been released for the 07/15/2016 settlement date, which shows a 523,826 share increase in total short interest for Five Prime Therapeutics, Inc , to 3,441,775, an increase of 17.95% since 06/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.